<DOC>
	<DOCNO>NCT00142961</DOCNO>
	<brief_summary>Attention Deficit Hyperactivity Disorder ( ADHD ) common among adolescent seek treatment marijuana dependence . The purpose study determine use atomoxetine treat adolescent abuse marijuana ADHD . In addition , study ass whether atomoxetine reduces ADHD symptom compare placebo . Finally , study determine whether atomoxetine improves treatment retention progress adolescent ADHD marijuana dependence .</brief_summary>
	<brief_title>Atomoxetine Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder</brief_title>
	<detailed_description>Attention Deficit Hyperactivity Disorder ( ADHD ) common among adolescent seek treatment marijuana dependence . Therefore , important develop treatment target adolescent diagnose ADHD marijuana dependence . Atomoxetine currently use treat individual diagnose ADHD . The purpose study determine feasibility administer atomoxetine therapeutic setting adolescent abuse marijuana ADHD . In addition , study ass whether atomoxetine reduces ADHD symptom . Finally , study determine whether atomoxetine improves treatment retention progress adolescent ADHD marijuana dependence . Participants double-blind study randomly assign receive either atomoxetine placebo . Study visit occur 2 time week duration 12-week trial . At study visit , vital sign medication side effect assess . In addition , psychiatric rating measurement evaluate . Participants also complete self report order track ADHD-related symptom . Starting Week 2 study visit , participant receive psychotherapy session . This involve cognitive-behavioral therapy/relapse prevention treatment design specifically ADHD adolescent . The aim cognitive skill train assist participant develop skill necessary manage drug use well symptom experience related ADHD . At Month 6 , follow-up visit occur , time participant urine toxicology test complete determine participant use marijuana substance abuse . In addition , Month 6 follow-up visit , participant complete psychiatric rating , self report , meet physician ass ADHD-related symptom .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Meets DSMIV criterion marijuana dependence report marijuana primary drug abuse Meets DSMIV criterion ADHD , determine CAADID Females include pregnant breastfeeding , agree use adequate method contraception duration study Meets DSMIV criterion schizophrenia , schizoaffective illness , psychotic disorder transient psychosis due drug abuse , current major depression , bipolar illness , psychiatric disorder ( individual substanceinduced mood disorder depressive feature well substance induce anxiety disorder exclude study ) Medically unstable ( base laboratory test , electrocardiogram , medical history , physical examination ) study participation would hazardous ; example include uncontrolled high blood pressure faster normal heart rate ( systolic blood pressure great 130 , diastolic blood pressure great 80 , rest heart rate great 90 ) diabetes History seizure Current suicidal risk Pregnant breastfeed Physiologically dependent drug ( exclude nicotine ) require medical intervention Known sensitivity atomoxetine Prior treatment failure atomoxetine Currently receive effective treatment atomoxetine Coronary vascular disease , indicate history suspect abnormal ECG history cardiac symptom Currently take psychotropic medication Currently take cough medicine ( e.g. , dextromethorphan ) albuterol Currently take history take monoamine oxidase inhibitor ( MAOIs ) within 2 week prior enrollment Narrow angle glaucoma Hepatitis Adolescents prisoner define OHRP regulation , namely directly courtmandated adolescent ( oppose probation parolemandated client , well voluntary client , exclude )</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>cannabis abuse</keyword>
	<keyword>atomoxetine</keyword>
	<keyword>ADHD</keyword>
</DOC>